Novo Nordisk ups guidance after Q1 results beat expectations squib

Denmark's Novo Nordisk, the world's biggest manufacturer of diabetes drugs, raised its financial forecast in local currencies on Wednesday after reporting first quarter sales and earnings above expectations. "We are very encouraged with the sales growth in the first three months of 2021," Chief Executive Lars Fruergaard Jorgensen said. "Sales growth was driven by all therapy areas and across geographical areas."
Continue reading on Yahoo! Sports...